CTI BioPharma
CTIC
#5622
Rank
NZ$2.08 B
Marketcap
NZ$15.78
Share price
0.00%
Change (1 day)
33.57%
Change (1 year)

CTI BioPharma (CTIC) - Total liabilities

Total liabilities on the balance sheet as of March 2023 : NZ$0.23 Billion

According to CTI BioPharma 's latest financial reports the company's total liabilities are NZ$0.23 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

CTI BioPharma - Total liabilities on balance sheet (from 2001 to 2023)

Total liabilities by year

Year Total liabilities Change
2022-12-31NZ$0.22 B124.83%
2021-12-31NZ$0.10 B298.29%
2020-12-31NZ$25.24 M-40.04%
2019-12-31NZ$42.09 M-23.46%
2018-12-31NZ$55 M0.68%
2017-12-31NZ$54.62 M-32.53%
2016-12-31NZ$80.96 M-42.82%
2015-12-31NZ$0.14 B106.2%
2014-12-31NZ$68.67 M10.73%
2013-12-31NZ$62.01 M25.14%
2012-12-31NZ$49.55 M13%
2011-12-31NZ$43.85 M-42.39%
2010-12-31NZ$76.13 M-37.42%
2009-12-31NZ$0.12 B-62.43%
2008-12-31NZ$0.32 B36.72%
2007-12-31NZ$0.23 B-17.98%
2006-12-31NZ$0.28 B-24.83%
2005-12-31NZ$0.38 B7.19%
2004-12-31NZ$0.35 B1.89%
2003-12-31NZ$0.35 B28.45%
2002-12-31NZ$0.27 B-41.45%
2001-12-31NZ$0.46 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Amgen
AMGN
NZ$139.79 B 58,410.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$135.92 B 56,788.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Incyte
INCY
NZ$2.91 B 1,120.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
NZ$24.05 B 9,966.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$158.13 B 66,086.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
NZ$56.60 B 23,590.04%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Novartis
NVS
NZ$108.57 B 45,342.13%๐Ÿ‡จ๐Ÿ‡ญ Switzerland